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Tissue-resident memory T cells (TRMs) in mice
mediate optimal protective immunity to infection
and vaccination, while in humans, the existence
and properties of TRMs remain unclear. Here, we
use a unique human tissue resource to determine
whether human tissue memory T cells constitute a
distinct subset in diverse mucosal and lymphoid
tissues. We identify a core transcriptional profile
within the CD69+ subset of memory CD4+ and CD8+
T cells in lung and spleen that is distinct from that
of CD69 TEM cells in tissues and circulation and
defines human TRMs based on homology to the tran-
scriptional profile of mouse CD8+ TRMs. Human
TRMs in diverse sites exhibit increased expression
of adhesion and inhibitory molecules, produce both
pro-inflammatory and regulatory cytokines, and
have reduced turnover compared with circulating
TEM, suggesting unique adaptations for in situ
immunity. Together, our results provide a unifying
signature for human TRM and a blueprint for
designing tissue-targeted immunotherapies.
INTRODUCTION
The establishment and maintenance of long-term immunity
depends on the generation of memory T cells that can populate
diverse tissue sites. The effector-memory (TEM) subset (Sallusto
et al., 1999) is the predominant subsetmigrating throughmultiple
tissues (Masopust et al., 2001); however, a significant fraction of
TEM-phenotype cells persist as non-circulating subsets of
tissue-resident memory T cells (TRMs) inmultiple sites, including
lungs, intestines, skin, liver, brain, and other mucosal surfaces
(for reviews, see Mueller and Mackay, 2016; Schenkel andCell Report
This is an open access article under the CC BY-NMasopust, 2014; Thome and Farber, 2015). TRMs mediate
optimal protective responses to site-specific infections through
rapid mobilization of immune responses in situ (Schenkel et al.,
2014a; Teijaro et al., 2011). Mouse models have also demon-
strated the feasibility of targeting TRMs in vaccines for gener-
ating protective immunity (Shin and Iwasaki, 2012; Zens et al.,
2016). Given their potential importance in immune protection
and tissue homeostasis, an understanding of TRM identity, func-
tion, and regulation in humans is essential for translating strate-
gies to target tissue-specific responses for protection and
immunomodulation.
Advances in human TRM biology are limited by the lack of
assays to distinguish circulating and resident memory T cells in
tissues. In mice, tissue retention demonstrated by parabiosis
(Jiang et al., 2012; Steinert et al., 2015) and in vivo antibody
labeling (Anderson et al., 2014; Turner et al., 2014) identified
phenotypic markers associated with tissue residence, including
CD69 and CD103. In mice, CD69 is expressed by the majority of
CD4+ and CD8+ TRMs in multiple sites (Jiang et al., 2012; Maso-
pust et al., 2006; Schenkel et al., 2013; Teijaro et al., 2011), while
CD103 is only expressed by certain subsets of CD8+ TRM
(Bergsbaken and Bevan, 2015; Mueller and Mackay, 2016) and
not significantly by CD4+ TRM (Thom et al., 2015; Turner et al.,
2014). CD69 has also been shown to have tissue-retention func-
tions in lymph nodes through sequestration of the sphingosine-
1-P receptor (S1PR) that mediates egress of T cells (Matloubian
et al., 2004; Shiow et al., 2006) and is required for TRM retention
in the skin (Mackay et al., 2015). Whether CD69 can delineate
TRMs from circulating TEM counterparts remains to be estab-
lished in humans and is a critical outstanding question in the
field.
In human tissues, we and others have identified and charac-
terized TRM phenotype cells expressing CD69 and/or CD103
in multiple sites, including lungs, liver, lymphoid sites, skin, and
intestines (Hombrink et al., 2016; Pallett et al., 2017; Purwar
et al., 2011; Sathaliyawala et al., 2013; Thome and Farber,
2015; Thome et al., 2014; Watanabe et al., 2015; Wong et al.,s 20, 2921–2934, September 19, 2017 ª 2017 The Author(s). 2921
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2016;Woon et al., 2016). However, it is not knownwhether TRMs
represent a distinct subset in humans for both CD8+ and CD4+
T cell lineages, with unifying functional, phenotypic, and tran-
scriptional signatures across tissues and individuals.
We have established a human tissue resource to obtain
blood and multiple lymphoid and mucosal tissues from previ-
ously healthy organ donors, enabling analysis of T cell com-
partmentalization and maintenance throughout life (Gordon
et al., 2017; Sathaliyawala et al., 2013; Thome et al., 2014,
2016a, 2016b). We present here transcriptional, phenotypic,
and functional analyses that define human TRMs as a distinct
subset in multiple sites. We show that CD69 is a key marker
that distinguishes memory T cells in tissues from those in cir-
culation, while CD103 is expressed only by a subset of tissue
memory CD8+ and not by CD4+ T cells. CD69+ tissue memory
T cells are transcriptionally and phenotypically distinct from
CD69 memory T cells in tissues and blood and exhibit a
core gene profile comprising adhesion, migration, and regula-
tory molecules with homology to mouse TRMs. This core
signature is shared between human CD4+ and CD8+ TRM
and in multiple lymphoid and mucosal tissues. Further, human
TRMs have an enhanced capacity for production of certain
cytokines and regulatory molecules and decreased turnover
compared to circulating TEM cells, suggesting long-term main-
tenance in situ. Together, our study establishes human TRMs
as a distinct subset stably maintained in diverse anatomic
locations.
RESULTS
CD69+Memory Populations Exist Only in Tissues and Do
Not Show Evidence of Activation
To identify the major phenotypic marker distinguishing tissue
from circulating memory T cells, we assessed CD69 and
CD103 expression as markers associated with TRMs in mice
by CD45RA/CCR7 TEM-phenotype CD4+ and CD8+ T cells
in blood and 8 tissue sites of individual donors (Figures 1A
and 1B). We focused on TEM cells as the major memory subset
in tissues that is common to both CD4+ and CD8+ T cells as
previously determined (Thome et al., 2014). While blood mem-
ory T cells were predominantly CD69/CD103, the majority
(>50%–90%) of tissue memory CD4+ and CD8+ T cells in all
sites examined—including lungs, intestines, salivary glands,
tonsils, spleen, and various lymph nodes (LNs)—expressed
CD69 (Figures 1A and 1B). CD103 was expressed predomi-
nantly by memory CD8+ T cells in tissues associated with
the oral-gastrointestinal tract (salivary glands, tonsils, and
intestines) and lung, with significantly lower proportions of
CD103+CD8+ memory T cells in spleen and lymph nodes
(10%–30%), with few tissue memory CD4+ T cells expressing
CD103 (<5%–10%; Figures 1A and 1B). Together, these find-
ings indicate that CD69 expression distinguishes tissue from
blood TEM across multiple lymphoid and barrier tissues and
CD4/CD8 lineages, while CD103 expression is more variable
and confined to certain tissue CD8+ T cells.
Because CD69 is also a marker of early activation, we
assessed the expression of the activation markers CD25,
CD38, and HLA-DR by CD69+ and CD69 memory subsets2922 Cell Reports 20, 2921–2934, September 19, 2017from representative lymphoid (spleen) and mucosal (lung) tis-
sues. There was uniformly low expression of CD25, CD38, and
HLA-DR on CD69+ TEM cells similar to expression levels on
resting naive T cells (Figure 1C). Previously, we also found main-
tenance of CD28 and CD127 expression by the majority of
CD69+ tissue memory T cells, indicative of a quiescent state
(Thome et al., 2014). Together, our results show that CD69
expression by tissue memory T cells is not associated with
markers of recent activation.
Human CD69+ Tissue Memory T Cells Constitute a
Transcriptionally Distinct Subset with Features of
Tissue Residency
Based on the aforementioned phenotype analysis, we hypothe-
sized that human TRMs could be found within the CD69+ subset
of tissue memory T cells. We isolated CD4+ and CD8+ TEM cells
from the spleen and lungs of 3 previously healthy organ donors
(sorting strategy is shown in Figure 1D; donor information is
shown in Table S1), fractionated them into CD69+ and CD69
subpopulations for whole-transcriptome profiling by RNA
sequencing (RNA-seq), and analyzed the resultant profiles of
CD69+ and CD69 subsets for each lineage and tissue. Prin-
cipal-component analysis (PCA) revealed that the transcriptome
of CD69+ cells was distinct from that of the CD69 subset for
CD4+ and CD8+ memory T cells in spleen and lung tissue for
all three donors analyzed (Figure 2A). This result indicates that
CD69 expression defines a transcriptionally distinct subset of
memory T cells in human tissues.
Applying the criteria for significance (false discovery rate [FDR]
% 0.05, and absolute value of log2 fold change R 1), for CD4
+
samples, we identified 327 genes differentially expressed
between lung CD69+ and CD69 subsets and 221 genes differ-
entially expressed between spleen CD69+ and CD69 subsets,
of which 77 genes (29 upregulated, 48 downregulated) were
differentially expressed in both tissues (Figures 2B and 2C).
For CD8+ samples, we identified 329 genes differentially
expressed between lung CD69+ and CD69 subsets and 459
genes differentially expressed between spleen CD69+ and
CD69 subsets, of which 133 genes (39 upregulated, 94 down-
regulated) were differentially expressed in both tissues (Figures
2B and 2C). The expression differences in these key genes
were similar between three donors (Figure 2C).
The genes differentially expressed by human CD69+ and
CD69 TEM cells (Figure 2C) included key molecules associ-
ated with mouse CD8+ TRMs from infection models (Mackay
et al., 2013, 2016; Skon et al., 2013; Wakim et al., 2012).
Notably, downregulation of S1PR1 and its associated tran-
scription factor KLF2 are required for CD8+ TRM establishment
in mice (Skon et al., 2013), and we found striking downregula-
tion of S1PR1 (8- to 16-fold) and KLF2 (2- to 16-fold) tran-
scripts for all CD69+ subsets compared with CD69 subsets
in every donor for both CD4+ and CD8+ T cells in lung and
spleen (Figure 2D). In addition, human CD8+CD69+ subsets
exhibited upregulation of ITGAE (CD103), ITGA1 (CD49a),
ICOS, and the transcription factor IRF4, which was also found
to be upregulated by mouse CD8+ TRMs in different systems
(Mackay and Kallies, 2017). Together, these results
show that the CD69+ tissue memory T cells constitute a
Figure 1. CD69+ Memory T Cells Are Prevalent in Tissues and Do Not Show Features of Activation
(A) Expression of CD69 and CD103 by CD4+ (top) and CD8+ (lower) memory T cells (CCR7CD45RA) within each indicated site from one individual (donor 332)
representative of 6 donors. LLN, Lung lymph node; ILN, inguinal lymph node; MLN, mesenteric lymph node.
(B) Mean frequency (± SEM) of CD69+CD103 (gray) and CD69+CD103+ (blue) CD4+(left) and CD8+ (right) memory T cells in each tissue compiled from 16–22
donors per site.
(C) Activation profile of T cells from human tissues. Flow cytometry plots show expression of CD25, CD38, and HLA-DR by naive T cells (CCR7+ CD45RA+, blue
line), and CD69 (black) and CD69+ (red) subsets of memory T cells (CCR7CD45RA). Data are representative of 3 donors.
(D) Sorting strategy for isolation of CD4+ and CD8+ CD45RACCR7CD69+ and CD45RACCR7CD69 T cells for RNA-seq is shown from spleen.transcriptionally distinct subset enriched for features of tissue
residency.
We further compared the transcriptional profiles of tissue
memory T cell subsets with circulating TEM cells isolated from
the blood of three healthy volunteers. PCA using the gene signa-
ture in Figure 2C resulted in clustering of blood TEM with CD69tissue TEM, distinct from CD69+ samples, which clustered
together (Figure 2E). By contrast, PCA using an equal number
of randomly selected genes as a negative control yielded no
clustering pattern (Figure S1). This grouping suggests that
CD69 expression by memory T cells in tissues distinguishes
circulating memory subsets from those retained in tissues.Cell Reports 20, 2921–2934, September 19, 2017 2923
Figure 2. CD69 Expression Defines a Transcriptionally Distinct Memory Subset in Humans with Features of Tissue Residency
Whole-transcriptome profiling by RNA-seq was performed on CD69 and CD69+ subsets of CD4+ and CD8+ memory T cells from spleen and lungs of 3 donors
(donors 226, 233, and 250; see Experimental Procedures).
(A) Principal-component analysis (PCA) of paired CD69+ and CD69 samples from spleen and lung and for CD4+ and CD8+ subsets, based on the global
transcriptome (20,000 genes).
(legend continued on next page)
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ACore Gene Signature of Human CD69+ Memory T Cells
Based on the gene expression analysis in Figure 2, we identified
31 core genes with consistent significant differential expression
by CD4+ and CD8+ CD69+ compared with the corresponding
CD69 subset from lung, spleen, and blood (Figure 3A; Table
S2). This core signature included upregulation of the adhesion
markers ITGAE (CD103) and ITGA1 (CD49a); the chemokine re-
ceptors CXCR6 and CX3CR1; and molecules with known inhib-
itory functions in T cells, including PDCD1 (PD-1) (Barber et al.,
2006), the dual-specificity phosphatase DUSP6 that turns off
MAP kinase signaling (Bertin et al., 2015), and interleukin
(IL)-10. Downregulated genes within the core signature included
S1PR1 and its associated transcription factor KLF2, which
together control T cell homing and tissue retention (Skon et al.,
2013); the related Kruppel-like transcription factor KLF3; and
the lymph node homing receptor SELL (CD62L); as well as
RAP1GAP1 and RGS1, G-protein-signaling genes that modulate
T cell trafficking (Gibbons et al., 2011).
Pathways represented within the core signature include those
controlling T cell adhesion and migration, proliferation, develop-
ment, and activation (Table S3) that interconnect as diagrammed
in Figure 3B.Many of the upregulated genesmap downstream of
T cell receptor (TCR) signaling, including CD69, adhesion mole-
cules (ITGA1, ITGAE, and CRTAM), and activation-induced
molecules IL-2, IL-10, and PD-1 that can regulate proliferation
(Figure 3B). Differential upregulation or downregulation of spe-
cific chemokines and chemokine receptors (CXCL13, CXCR6,
CX3CR1, SELL, and S1PR1) and modulation of G-protein-medi-
ated signaling (Figure 2B) indicate that tissue residence involves
specific tuning of migratory properties. Overall, these results
establish that human CD69+ tissue memory T cells maintain a
core signature impinging on multiple signaling pathways
affecting cellular migration, function, and proliferation.
The relative transcript levels of key genes within the core gene
signature (ITGA1 [CD49a], CXCR6, ITGAE [CD103], CXCR6,
CX3CR1, and PD-1) showed differential regulation between
CD69+ and CD69 subsets that was consistent across tissues,
lineages, and diverse donors (Figures 3C–3G). We also vali-
dated differential surface protein expression for each marker
compiled from 8 to 20 donors (Figures S2 and S3; discussed
later). Interestingly, for a number of genes (ITGAE, CX3CR1,
and PDCD1), there was an expression gradient from blood to
tissue CD69 to CD69+ subsets, with bloodmemory cells exhib-
iting lower (ITGAE and PDCD1) or higher (CX3CR1) expression
than CD69 subsets from tissues (Figures 3D, 3F, and 3G), sug-
gesting some differences between CD69 subsets in blood and
tissues. Together, these data establish CD49a, CD103, CXCR6,
CX3CR1, and PD-1 as core surface markers that distinguish(B) Diagram shows the number of significant differentially expressed genes (FDR
each tissue for CD4+ and CD8+ T cells showing overlap between tissues.
(C) Heatmap showing normalized expression levels of the overlap genes identified
from spleen (S) and lung (L).
(D) Transcriptional downregulation of S1PR1 and KLF2 in all CD69+ subsets ve
(bottom) transcripts in CD69 and CD69+ samples from spleen (S) and lung (L) of e
lines connect samples from identical donors within a tissue.***FDR% 103; ****F
(E) PCA of CD69+ (red) and CD69 (black indicates tissue; blue indicates blood)
See also Figure S1 and Table S6.human CD69+ and CD69 memory subsets across tissues
and lineages.
The HumanCD69+ TissueMemory Core Signature Bears
Key Homologies with Mouse TRMs
To determine whether the core transcriptional profile common to
CD69+ memory T cells in spleen and lungs defined a TRM signa-
ture, we compared the RNA-seq profile of the human tissue and
blood subsets with that of mouse antigen-specific CD8+ TRMs
isolated from skin and intestines following infection (Mackay
et al., 2016). PCA of whole transcriptomes shows species-spe-
cific transcriptional differences between human and mouse
T cells dominating, with all human samples clustering together
distinct from mouse TRM/TEM, and mouse samples forming
distinct clusters based on the infection model (Figure 4A, left).
When analyzed based on the human core gene signature in Fig-
ure 3, CD4+CD69+ and CD8+CD69+ subsets from human spleen
and lung cluster together with mouse CD8+ TRMs from skin and
gut in the two different infection models and are distinct from all
TEM/CD69 counterparts (Figure 4A, right). Gene set enrich-
ment analysis (GSEA) (Subramanian et al., 2005) also revealed
a strong enrichment of the differentially expressed genes in
human CD4+CD69+ and CD8+CD69+ subsets within the gene
signatures of TRMs from mouse brain (Wakim et al., 2012) and
from mouse skin and lung (Mackay et al., 2013) (Figure 4B).
Taken together, our results show that the gene signature of
human CD69+ tissue memory T cells exhibits key features of
TRMs and likely contain the human TRM subset.
A recent report showed that mouse CD8+ TRM in multiple tis-
sues exhibit biased expression of the Hobit (homolog-of BLIMP
in T cells) transcription factor, which can drive TRM differentia-
tion in vivo (Mackay et al., 2016). As Hobit was not part of the
core gene set in our analysis, we specifically analyzed the
expression level of Hobit (ZNF683) by human CD69+ memory
T cells compared with mouse TRMs. In mouse TRMs, Hobit
levels were higher than the housekeeping gene GAPDH and
comparable to CD69 transcript levels. By contrast, for human
CD69+ memory T cells, Hobit transcript levels were below me-
dian gene expression and significantly lower than GAPDH and
CD69 levels (Figure 4C). These results suggest distinct molecular
control of human and mouse TRM differentiation, despite similar
core signatures.
Reduced Clonal Overlap and Proliferative Turnover of
CD69+ Compared with CD69 Memory T Cells
We compared the TCR repertoires of lung and spleen CD69+ and
CD69 memory T cell subsets using a recently developed algo-
rithm TRUST (TCR Repertoire Utilities for Solid Tissue) (Li et al.,% 0.05, and log2 fold changeR 1) between CD69
 and CD69+ samples within
in (B) for CD4+ (77 genes) and CD8+ (133 genes) CD69 versus CD69+ subsets
rsus CD69 subsets. Normalized expression levels of S1PR1 (top) and KLF2
ach donor are shown. Individual donors are indicated by distinct symbols, and
DR% 105.
memory subsets based on the genes in (C). S, spleen; L, lung; B, blood.
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Figure 3. A Core Gene Signature Defines Tissue CD69+ Memory T Cells Distinct from Circulating CD69 Cells in Tissues and Blood
(A) Heatmap shows normalized expression of genes with significant differential expression between CD69+ and CD69memory T cells for all subsets (CD4+ and
CD8+) and tissues (spleen and lung).
(B) Network analysis of the core gene set in (A) showing known and predicted interactions (activating, inhibitory) between proteins encoded by the core genes that
are upregulated (red) or downregulated (green) by TRMs compared with TEM, with key pathways indicated in the shaded boxes. Relationships were determined
using IPA software, the STRING protein database, GeneCards, and PubMed literature searches.
(C–G) Normalized mRNA expression levels of ITGA1 (C), ITGAE (D), CXCR6 (E), CX3CR1 (F), and PDCD1 (G) by CD4+ and CD8+ CD69+ and CD69 memory
subsets in blood (B), spleen (S), and lung (L) of each individual donor. *FDR % 0.05; ** FDR % 102; ***FDR % 103; and ****FDR % 105. Each donor is
represented by a unique shape as indicated.
See also Figures S2 and S3.
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Figure 4. Comparison of the Human and Mouse TRM Transcriptome
(A) PCA was performed using RNA-seq data presented here (black symbols) compared to mouse herpes simplex virus (HSV)-specific CD8+ TRMs from skin and
CD8+ TEM from spleen (‘‘Mouse HSV,’’ yellow) and LCMV-specific CD8+ TRMs from intestine and CD8+ TEM from spleen (‘‘Mouse LCMV,’’ red) (Mackay et al.,
2016). Left: PCA comparing whole transcriptomes of each dataset comprising 15,571 common genes between human andmouse. Right: PCA comparing human
and mouse datasets using the core human signature of 31 genes (Figure 3).
(B) Gene set enrichment analysis (GSEA) comparing our human CD8+ (left) and CD4+ (left) gene sets to published microarray data of CD103+ brain TRMs versus
spleen TEM (top row), gut TRMs versus spleen TEM (middle row), and lung TRMs versus spleen TEM (bottom row) (Wakim et al., 2012; Mackay et al., 2013). In
each plot, the x axis shows the genes ranked with absolute value of log fold change between TRMs versus TEM, and the y axis shows the running enrichment
score (ES), comparing the ranked list of genes with indicated p values.
(C) Comparison of Hobit gene expression in mouse and human datasets. Violin plots show the Z score of gene expression levels frommouse TRMs (fromMackay
et al., 2016) and human CD69+ memory T cells (this study). Red dots represent Hobit, blue dots represent the housekeeping gene GAPDH, green dots represent
CD69, and the white dot represents median gene expression.2017) to extract TCR sequences from theRNA-seq reads (Supple-
mental Experimental Procedures). Between 0.1% and 0.3% of
mapped reads could be assigned to the TCR region (data not
shown), with detection of several hundred to over 1,000 unique
clonotypes per sample (Figure S4). From these data, we
measured clonal diversity (number of unique clonotypes per
TCR-mapped reads) and overlap between sites. Overall, CD69and CD69+ cells exhibited similar clonal diversity with CD4+ sub-
sets maintaining higher clonal diversity compared to CD8+ mem-
ory subsets (Figure 5A), consistent with our previous findings
showing increased clonality of memory CD8+ compared to
CD4+ T cells from lymphoid sites (Thome et al., 2014). Clonal over-
lap between sites was minimal (<1%) for CD4+ subsets, while
CD8+CD69+ cells exhibited significantly reduced overlap betweenCell Reports 20, 2921–2934, September 19, 2017 2927
Figure 5. TCR Clonal Analysis, Turnover, and Function of CD69+ and CD69 Cells
(A) CD8+ T cells have reduced TCR repertoire diversity compared with CD4+ cells. CDR3 sequences were inferred from RNA-seq data using TRUST (Supple-
mental Experimental Procedures). Graph shows the number of unique CDR3 calls (clonotypes) in each sample per 103 reads mapped to the TCR region.
(B) Increased tissue overlap of TCR cloneswithin CD8+ CD69 compared to CD69+memory T cells. Graph shows percentage of overlapping clones between lung
and spleen samples from each donor, calculated by dividing the total number of overlapping clones by the total number of unique clones present in both tissues.
(C) Reduced proliferative turnover by CD69+ memory T cells. Left: representative flow cytometry plots of intracellular Ki67 expression from spleen and lungs of
one individual donor. Right: Ki67 expression compiled from 10 donors indicated as mean frequency KI67+ ± SEM.
(D) Increased CD57 expression by CD69 compared to CD69+ cells. Left: CD57 expression by CD69 and CD69+memory T cell subsets from spleen and lung of
one representative donor. Right: CD57 expression compiled from 11 donors indicated as mean percent positive ± SEM. *p% 0.05; **p% 0.01.
(legend continued on next page)
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lung and spleen compared to CD8+CD69 cells (Figure 5B), indi-
cating that CD69+ memory T cells are more clonally segregated
within the tissue compared to CD69 cells. These results provide
some additional evidence that CD69+ memory T cells may be
more retained in the tissue site compared with CD69 cells.
We hypothesized that the biased maintenance of CD69+
clones in certain sites may indicate reduced turnover. The fre-
quency of CD69+ cells expressing Ki67, a marker of proliferating
cells, was markedly reduced relative to CD69 cells in both
spleen and lung (Figure 5C). Examination of CD57 expression,
a marker of replicative senescence and terminal differentiation
(Kared et al., 2016), revealed lower CD57 expression by
CD8+CD69+ cells compared to CD8+CD69 cells in both spleen
and lung. Taken together, these data suggest that human CD69+
memory T cells undergo reduced proliferative turnover and have
reduced clonal overlap compared with CD69 cells.
Human CD69+ Memory T Cells Have a Distinct
Functional Profile
We investigated cytokine production by CD69+ and CD69 cells
based on differential transcript expression of genes encoding
IL-2, interferon (IFN)-g, IL-17, and IL-10, identified as signifi-
cantly upregulated by CD69+ versus CD69 memory T cells for
the CD4+ and/or CD8+ subsets (Figures 2C and 3A). IL-2 and
IL-10 were produced by a consistently higher proportion of
CD69+ compared with CD69 memory T cells for both CD4+
and CD8+ subsets in spleen and lung (Figures 5E and 5F),
consistent with increased IL2 and IL-10 transcription being
part of the core signature (Figure 3A). IFN-g was produced by
spleen and lung memory CD4+ and CD8+ T cells, with spleen
CD69+ memory T cells exhibiting increased IFN-g production
compared with CD69 cells, while lung CD69+ and CD69 cells
had comparable IFN-g production (Figure 5G, left). IL-17 was
produced more extensively by lung CD4+ and CD8+CD69+
compared with lung CD69memory T cells, and not significantly
by spleen CD69+ and CD69 cells (Figure 5G, right). Together
these results indicate that the functional capacity of CD69+
memory T cells comprises core features (e.g., IL-2 and IL-10
production) along with subset and tissue influences.
The TRM Transcriptional Profile Is Conserved across
Lineages and Tissues
Isolation of both CD4+ and CD8+memory T cell subsets from two
tissue sites of individual donors enabled us to assess lineage-
and tissue-specific gene expression patterns. To identify line-
age-specific genes, we compared differential gene expression
by CD8+ CD69+ versus CD69 and CD4+ CD69+ versus CD69
subsets for each tissue site. Themajority of genes showed similar
differential expression in terms of direction andmagnitude of fold(E–G) Distinct functional profile of CD69+ cells. CD4+ and CD8+ CD69 and CD6
ionomycin, and cytokine production was assessed by intracellular cytokine stai
beads (for IL-10), and IL-10 levels in the supernatant were assessed by BD Cyto
CD69+ cells producing IL-2. (F) Graph indicates means ± SEM. IL-10 production is
and CD69+ cells producing IFN-g (left) and IL-17A (right) ± SEM.
n = 6 donors (spleen); ns = 10 donors (lung) for IL-2, IFN-g, and IL-17 and 3 dono
cytokine production (<5%).
See also Figure S4 and Supplemental Experimental Procedures.changewhen lookingatCD69+versusCD69 subsets fromeither
CD8+ or CD4+ lineages (Figure 6A). From a total of 907 genes that
were differentially expressed by at least one of our CD69+ versus
CD69 pairs, there were 4 protein-coding genes that showed
differential expression in CD4+, but not in CD8+, subsets and
27 genes that showed significant differential expression in
CD8+, but not in CD4+, subsets (Figures 6A, S5A, and S5B).
Together, these results indicate that the differential expression
profile of human CD69+ tissue memory T cells is similar across
CD4+ and CD8+ lineages.
We applied a similar type of analysis as in Figure 6A to identify
genes specific to lung or spleen memory T cells (Figure 6B). Only
10 genes showed differential expression in CD69+ versus CD69
in lung, but not spleen, samples and 12 genes that showed sig-
nificant differential expression in CD69+ versus CD69 in spleen,
but not lung, samples (Figures 6B, S5C, and S5D). Notably,
CD101, encoding a cell-surface immunoglobulin superfamily
protein that inhibits T cell activation and proliferation (Soares
et al., 1998), was transcriptionally upregulated in lung, compared
to spleen, memory T cells. However, examination of CD101 sur-
face expression by flow cytometry revealed increased expres-
sion by CD8+CD69+ compared with CD69 cells in both lung
and spleen, with minimal upregulation by CD4+ tissue memory
subsets (Figure 6C). These results indicate that CD101 could
be an additional marker for CD8+ TRMs.
TRMs Are a Phenotypically Distinct Subset across
Multiple Tissues
We asked whether multiple elements within the core signature
together distinguished tissue memory subsets in spleen and
lung using t-distributed scholastic neighbor embedding (t-SNE)
analysis (van der Matten and Hinton, 2008; Wong et al., 2016),
a dimensionality reduction method used to visualize high-dimen-
sional data in two dimensions so that cells expressing similar
markers will be close to each other. Based on the expression
of 6 markers defined as part of the core TRM signature
(Figure 3)—CD49a, CD103, CXCR6, CX3CR1, PD-1, and
CD101—we found that CD69+ and CD69 subsets were located
in distinct regions of the t-SNE plots for both CD4+ and CD8+
T cells in each tissue (Figure 7A) and in density plots compiled
from both sites (Figure 7B, top). Manual gating within each domi-
nant cluster revealed that CD69 subsets exhibit elevated
expression of CX3CR1 and low expression of CD49a, PD-1,
CD101, and CXCR6 compared to CD4+ and CD8+CD69+ sub-
sets exhibiting high expression of CD49a, PD-1, and CXCR6
and low expression of CX3CR1, with CD8+CD69+ subsets hav-
ing coordinate expression of CD103 and CD101 (Figure 7B).
These results further support the designation of tissue CD69+
memory T cells as TRMs and the CD69 subset as TEM.9+ memory T cells isolated from spleens and lungs were stimulated with PMA/
ning (ICS) (for IL-2, IFN-g, and IL-17) or were stimulated with anti-CD3/CD28
metric Bead Array. (E) Graph shows mean frequency (± SEM) of CD69 and
given in picograms per milliliter. (G) Graph indicates mean frequency of CD69
rs for IL-10. *p < 0.05; **p < 0.01; ***p < 0.001. Unstimulated cells had minimal
Cell Reports 20, 2921–2934, September 19, 2017 2929
Figure 6. Lineage and Tissue-Specific
Transcription and Phenotypic Profiles in
Human CD69+ Memory T Cells
(A) Analysis of lineage-specific gene expression in
CD69+ and CD69 memory T cells. Scatterplots
display log2 fold change of CD4
+ CD69+ versus
CD69 on the x axis and CD8+ subsets on the
y axis from lung (left) and spleen (right). Gray dots
represent genes with significant differential
expression in any paired CD69+ versus CD69
sample. Orange dots (‘‘CD4 specific’’) represent
genes with significant differential expression in
CD4+ CD69+ versus CD69 but not in CD8+
samples. Green dots (‘‘CD8 specific’’) represent
genes with significant differential expression in
CD8+ CD69+ versus CD69 but not in CD4+
samples.
(B) Analysis of tissue-specific genes in CD69+ and
CD69 memory T cells. Scatterplots display log2
fold change of lung CD69+ versus CD69 samples
on the x axis and spleen samples on the y axis for
CD4+ (left) and CD8+ (right) T cells, using the same
strategy as in (A), with red dots denoting ‘‘spleen-
specific’’ and blue dots denoting ‘‘lung-specific’’
transcripts in the paired analysis.
(C) CD101 expression in human tissues. Repre-
sentative plots show CD101 expression in CD69+
(black outline) and CD69 (shaded) cells from one
individual donor. Data are representative of
15 donors.
See also Figure S5.We assessed how multiple phenotypic properties of the core
signature were distributed in diverse sites within an individual,
including in intestines, mesenteric lymph nodes, tonsils, and
blood in addition to lung and spleen (Figures 7C, 7D, and S6).
We initially generated t-SNE plots using concatenated data
from all six tissue sites, revealing phenotypically distinct TEM
and TRM subsets across multiple tissues (Figure 7C). In density
plots, CD4+ and CD8+ TEM cells were localized to the same
region of the t-SNE, suggesting that TEM phenotypes are
conserved across lineages and tissues (Figure 7C). By contrast,
CD8+ TRM and CD4+ TRMs appeared at different regions within
the t-SNE density plots distinct from TEM cells (Figure 7C).
Notably, there was a broader range of phenotypes based on
these markers within the CD4+ TRM subset compared with the
tighter clustering of CD8+ TRM phenotypes, suggesting
increased heterogeneity of CD4+ tissue memory T cells.
To compare the pattern of subset phenotypes between tis-
sues, we assigned distinct colors to CD8+ TRM, CD4+ TRM,
and TEM populations. Plotting all tissue samples on the same
t-SNE reveals the localization of each cell population (Figure 7D,
left), with TEM cells and CD4+ and CD8+ TRMs maintaining their
distinct clustering patterns and localization in each site (Figures
7D, right, and S6). In blood, TEM cells clustered in a pattern
similar to that of TEM in other tissues (Figure 7D, right), providing
additional evidence that TEM cells in tissues are circulating.2930 Cell Reports 20, 2921–2934, September 19, 2017Notably, CD8+ TRMs exhibit a focused
clustering pattern in all tissues, suggest-
ing that human TRMs represent a uniquesubset in multiple sites. CD4+ TRMs in all tissues exhibited a
broader array of phenotypes, suggesting increased heterogene-
ity of CD4+ TRMs compared to CD8+ TRMs throughout the body.
DISCUSSION
In this study, we provide key insights into TRM biology through
a comprehensive analysis of human CD4+ and CD8+ tissue
memory subsets in lymphoid and mucosal tissues within and
between multiple human donors. Our results establish that
human tissue memory T cells fractionated based on CD69
expression exhibit a core signature of 31 genes conserved
across tissues and lineages, with key homologies to the tran-
scriptional profile of mouse TRMs. We demonstrate that human
TRMs persist in multiple lymphoid, mucosal, and peripheral
tissue sites; exist within both CD4+ and CD8+ lineages; and
exhibit unique functional signatures, compared with circulating
TEM cells, including proinflammatory and regulatory capacities
and low turnover. Together, our results suggest that human
TRMs are a distinct developmental subset uniquely adapted
for in situ immunity.
A definitive phenotypic marker for human TRMs has not previ-
ously been defined. Transcriptional profiling has been reported
for mouse CD8+ TRMs in which CD8+ memory T cells isolated
from a barrier site (skin, intestine, or lung) were compared with
Figure 7. TRMs Are a Phenotypically
Distinct Subset across Multiple Tissues
Simultaneous expression of CD49a, CD103,
CD101, CXCR6, CX3CR1, PD-1, and CD69 was
visualized using t-SNE analysis.
(A) CD69+ and CD69 memory T cells are
phenotypically distinct in spleen and lung. Plots
show CD69+ memory T cells (color coded green)
and CD69 memory T cells (color coded black)
from the spleen and lungs of an individual donor
(donor 321) representative of 5 donors.
(B) Defining the phenotype of TRM and TEM
clusters. Regions with high cellular density were
manually gated within TEM (CD69), CD4+ TRM
(CD69+), and CD8+ TRM (CD69+) fractions (top
row). Histograms show expression levels of
CD49a, CD103, CD101, CXCR6, CX3CR1, and
PD-1 within gated regions (middle and bottom
rows).
(C and D) The core TRM phenotype is observed
across multiple tissues. Phenotype analysis, as in
(A), was performed using lung, intestine, spleen,
mesenteric lymph node (MLN), tonsil, and blood
samples from one representative donor (donor
332). (C) Plots show CD4+ (left) and CD8+ (right)
TRM and TEM subsets from all tissues with cell
number density color coded. (D) Plots shows cells
from all tissues (left large plot) or each individual
site (right smaller plots) color coded by cell type
(CD4+ TRM, red; CD8+ TRM, green; TEM, black) of
one donor representative of 4 donors.
See also Figure S6.T cells from spleen (Mackay et al., 2013, 2016). In human studies,
CD8+ TRMs isolated based on CD103 expression from individual
tissues (lung and skin) have been profiled in comparison to blood
subsets (Cheuk et al., 2017; Hombrink et al., 2016). Here, we
used an innovative and comprehensive approach to assess dif-
ferences in putative circulating and resident populations within
tissues by directly comparing CD69+ memory subsets from a
lymphoid and mucosal site (spleen and lung) with the corre-
sponding CD69 subset from each tissue, as well as CD69
TEM from blood for both CD4+ and CD8+ lineages. While
CD103 has been used to define CD8+ TRMs in mice (Schenkel
and Masopust, 2014) and humans (Hombrink et al., 2016), our
results demonstrate that CD69 expression can delineate tissueCell Reportsfrom circulating memory T cells based
on the following results: first, CD69 is
themajor marker that distinguishesmem-
ory T cells in diverse tissues from those in
circulation for CD4+ and CD8+ T cells,
while CD103 expression is limited to a
subset of tissue CD8+ T cells. Second,
CD69+ tissue memory T cells are a tran-
scriptionally and phenotypically distinct
subset that share core features with
mouse TRMs, while human tissue
CD69 cells share features with circula-
tory blood T cells. Finally, core pheno-
typic markers associated the CD69+subset such as CD49a, PD-1, CXCR6, and CD101 delineate
TRMs across multiple mucosal and lymphoid tissues.
Althoughwe found the TRMsignature to be enrichedwithin the
CD69+ subset of human tissue memory T cells, the role of CD69
in determining tissue residence remains unclear. In mouse
models, themajority of TRMs in barrier sites express CD69; how-
ever, TRMs lacking CD69 expression have been detected (Stei-
nert et al., 2015), and CD69+ cells in the thymus were shown to
recirculate during homeostasis (Park et al., 2016). However,
the extent of CD69 expression by tissue memory T cells appears
to be a function of antigen and pathogen exposure. We consis-
tently find higher frequencies of CD69 expression by human
tissue memory T cells compared to that found in mouse models20, 2921–2934, September 19, 2017 2931
maintained in specific pathogen free (spf) conditions, particularly
in lymphoid sites (Teijaro et al., 2011; Thome et al., 2014). Inter-
estingly, T cells in ‘‘dirty’’ pet store mice had significantly higher
frequencies of CD69 expression by T cells in tissues that was
similar to those in humans (Beura et al., 2016). In our results,
we consistently see separation of transcriptional profiles
between CD69+ and CD69 subsets (Figure 2), suggesting that
delineation between these subsets in humans may be more
defined than in mouse spf models due to the history of antigen
exposure.
The core TRM gene signature identified here includes canoni-
cal genes and proteins associated with tissue residence in
mice, including downregulation of S1PR1, KLF2, and CD62L; up-
regulation of specific adhesion molecules (CD49a and CRTAM);
modulation of specific chemokine receptors (increased CXCR6
and decreasedCX3CR1); and upregulation of inhibitory or regula-
tory molecules (PD-1, DUSP6, and IL-10). We also found TRMs to
exhibit a distinct functional profile encompassing pro-inflamma-
tory, activating, and regulatory functions conserved between
diverse individuals, tissues, and lineages. We further identified
a marker, CD101, with immunomodulatory function that is
expressed by CD8+ TRMs in multiple sites and could be useful
in conjunction with other markers to identify TRMs. We found
phenotypic heterogeneity based on the coremarkers, particularly
amongCD4+ TRMs, and additional tissue heterogeneity has been
reported in CyTOF profiling of human tissue T cells (Wong et al.,
2016). CD103 expression bymouse intestinal TRMs (Bergsbaken
and Bevan, 2015) and CD49a in human skin memory T cells
(Cheuk et al., 2017) have been shown to delineate distinct func-
tional capacities, and dissecting human TRM heterogeneity will
be an important area of focus in future studies.
The dominant presence of TRMs in human tissues suggests a
key protective role in situ. Our results reveal that human TRMs
possess dichotomous functional capacities, not only being
poised for enhanced production of IL-2 and pro-inflammatory
cytokines but also producing IL-10 and exhibiting reduced
proliferation and increased expression of inhibitors of T cell acti-
vation (i.e., PD-1 and CD101). This may enable the potent mobi-
lization of immune responses in situ through pro-inflammatory
cytokines but prevent excessive inflammation and cellular prolif-
eration to limit inflammation-induced tissue damage. Moreover,
the quiescent, inhibited state of TRMs as assessed by the low
turnover could promote longevity and prevent inappropriate acti-
vation to non-pathogenic antigens to which many human tissues
are continually exposed.
Our findings show that, in humans, TRMs exist in multiple tis-
sue sites and within CD4+ and CD8+ T cell lineages. While TRMs
have been detected in mouse lymph nodes (Schenkel et al.,
2014b; Ugur et al., 2014), the majority of mouse lymphoid mem-
ory CD4+ and CD8+ T cells in mice are circulating, particularly
those in the spleen. The predominance of TRM-phenotype cells
in all human lymphoid tissues examined here—including spleen,
lymph nodes, and tonsils—may reflect their long-term persis-
tence over decades and/or continual pathogen exposure,
consistent with a recent study identifyingmemory T cells specific
for persistent viruses in human tonsils (Woon et al., 2016). TRM
persistence in diverse sites may be due to the aggregate experi-
ence of numerous antigens over the human lifespan.2932 Cell Reports 20, 2921–2934, September 19, 2017Interest in TRMs is rapidly expanding to the study of many
diseases, from infection to cancer, to inflammation and autoim-
munity. In humans, it is essential to identify and analyze these
cells and determine whether they are functioning aberrantly in
disease sites. Our study elucidates major unifying features of
all tissue memory T cells in multiple healthy tissue sites within
an individual. These results will serve as a valuable baseline
from which to detect and study the role of tissue memory
T cells in diseases and for promoting tissue immunity in vaccines
as well as cell- and biologic-based immunotherapies.
EXPERIMENTAL PROCEDURES
Acquisition of Tissue from Human Organ Donors
Human tissues were obtained from deceased organ donors at the time of
organ acquisition for clinical transplantation through an approved research
protocol and material transfer agreement (MTA) with LiveOnNY, the organ
procurement organization for the New York metropolitan area. All donors
were free of chronic disease, cancer, hepatitis B, and hepatitis C, and were
HIV negative. Isolation of tissues from organ donors does not qualify as
‘‘human subjects’’ research, as confirmed by the Columbia University Institu-
tional Review Board (IRB). For isolation of blood from living volunteers, blood
was drawn via venipuncture from consented volunteers, as approved by the
Columbia University IRB. A list of donors and individuals from whom samples
were obtained for this study is presented in Table S1.
Cell Isolation from Human Lymphoid and Non-lymphoid Tissues
Tissue samples were maintained in cold saline and brought to the laboratory
within 2–4 hr of organ procurement. Spleen, lung, and intestinal samples
were processed using enzymatic and mechanical digestion, resulting in high
yields of live leukocytes, as described previously (Sathaliyawala et al., 2013;
Thome et al., 2014). Lymphocytes were isolated from blood samples using
centrifugation through lymphocyte separation medium (Corning) for recovery
of mononuclear cells.
Flow Cytometry Analysis and Cell Sorting
For flow cytometry analysis, single-cell suspensions were stained with fluoro-
chrome-conjugated antibodies (see Table S4 for all antibodies used in this
study) in staining buffer (PBS/1% fetal bovine serum/0.1% sodium azide).
Intracellular staining was performed using the Fixation/Permeabilization Solu-
tion Kit (BD Biosciences) for the detection of cytokines and Foxp3/Transcrip-
tion Factor Staining Buffer (eBioscience) for the detection of transcription
factors. Control samples included unstained, single fluorochrome-stained
compensation beads (UltraComp eBeads; eBioscience), and fluorescence-
minus-one (FMO) controls. Stained cells were acquired using the BD LSR II
or BD LSRFortessa. Data were analyzed using FlowJo software (Tree Star)
and FCS Express (De Novo Software). FCS Express software was used for
generating t-SNE plots. For isolation of subsets by fluorescence-activated
cell sorting, lymphocyte suspensions were enriched for T cells using the
MojoSort Human CD3 T Cell Isolation Kit (BioLegend), stained for surface
markers as indicated, and sorted using the BD Influx high-speed cell sorter
(BD Biosciences).
Whole-Transcriptome Profiling by RNA-Seq
CD3+CD4+ and CD3+CD8+ TEM (CD45RACCR7) cells were sorted into
CD69+ and CD69 subsets, based on the gating strategy in Figure S1, from
the spleen and lung tissue of three individual donors (D226, D233, and
D250; see Table S1), and CD4+ and CD8+ TEM cells (CD45RACCR7CD69)
were sorted fromperipheral blood. RNAwas isolated from cell pellets using the
RNeasy Mini Kit (QIAGEN) and quantitated using an Agilent 2100 Bioanalyzer
(Agilent Technologies), and library preparation and RNA-seq was performed
by the Columbia Genome Center. Differential gene expression analysis was
performed with EdgeR (Robinson et al., 2010), and pathway analysis was per-
formed with Ingenuity Pathway Analysis software (IPA; QIAGEN). For GSEA
with microarray data (Sua´rez-Farin˜as et al., 2010), the absolute value of log2
fold change between TRM and TEM cells was used to rank the genes on the
x axis. For a detailed description of RNA-seq procedures and analyses, see
Supplemental Experimental Procedures. For a quality control (QC) summary
of RNA-seq samples, see Table S5.
T Cell Stimulations and Cytokine Analysis
TEM cells (CD45CCR7CD69) and TRMs (CD45RACCR7CD69+) were
sorted from lung and spleen tissue, plated in 96-well round-bottom plates at
105 cells per well in complete RPMI medium, and stimulated for 72 hr using
anti-CD3/CD28/CD2 beads (T Cell Activation/Expansion Kit; Miltenyi Biotech).
Supernatants from aminimumof 3wells were pooled for each donor, and cyto-
kine secretion was measured using the BD Cytometric Bead Array (Human
Th1/Th2/Th17 Cytokine Kit). For short-term stimulations, CD4+ or CD8+
T cells from spleen and lung tissues were stimulated with Phorbol myristate
acetate (PMA) (50 ng/mL) + ionomycin (1 mg/mL) for 3 hr at 37C in the pres-
ence of BD GolgiStop. Cytokine production was assessed by intracellular
staining for cytokines as described earlier.
Statistical Analysis
Descriptive statistics (percent, mean, median, and SEM) were calculated for
each cell subset and tissue using Prism (GraphPad software). Significant
differences in subset frequencies, ratios, geometric mean fluorescence inten-
sity (gMFI), and density were assessed using a paired t test.
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